Atricure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.20), in-line with the analyst estimate of ($0.20). Revenue for the quarter came in at $29.4 million versus the consensus estimate of $28.4 million.

Atricure, Inc. sees FY2015 revenue of $122.5-124.5 million, versus the consensus of $122.43 million.

Adjusted EBITDA, a non-GAAP measure, is projected to be a loss in the range of $7 million to $9 million for 2015 as we continue to make strategic investments to drive our long-term growth plan.

For earnings history and earnings-related data on Atricure, Inc. (ATRC) click here.